BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 17194275)

  • 1. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.
    Freeman MP; Hibbeln JR; Wisner KL; Davis JM; Mischoulon D; Peet M; Keck PE; Marangell LB; Richardson AJ; Lake J; Stoll AL
    J Clin Psychiatry; 2006 Dec; 67(12):1954-67. PubMed ID: 17194275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
    Ross BM; Seguin J; Sieswerda LE
    Lipids Health Dis; 2007 Sep; 6():21. PubMed ID: 17877810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acids in the treatment of psychiatric disorders.
    Peet M; Stokes C
    Drugs; 2005; 65(8):1051-9. PubMed ID: 15907142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?
    Bozzatello P; Rocca P; Mantelli E; Bellino S
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized placebo-controlled trials of omega-3 polyunsaturated fatty acids in psychiatric disorders: a review of the current literature.
    Politi P; Rocchetti M; Emanuele E; Rondanelli M; Barale F
    Curr Drug Discov Technol; 2013 Sep; 10(3):245-53. PubMed ID: 21838664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of omega-3 fatty acids in the treatment of bipolar disorders: the current situation].
    Sempels C; Sienaert P
    Tijdschr Psychiatr; 2007; 49(9):639-47. PubMed ID: 17853373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.
    Sarris J; Ravindran A; Yatham LN; Marx W; Rucklidge JJ; McIntyre RS; Akhondzadeh S; Benedetti F; Caneo C; Cramer H; Cribb L; de Manincor M; Dean O; Deslandes AC; Freeman MP; Gangadhar B; Harvey BH; Kasper S; Lake J; Lopresti A; Lu L; Metri NJ; Mischoulon D; Ng CH; Nishi D; Rahimi R; Seedat S; Sinclair J; Su KP; Zhang ZJ; Berk M
    World J Biol Psychiatry; 2022 Jul; 23(6):424-455. PubMed ID: 35311615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data.
    Bozzatello P; Brignolo E; De Grandi E; Bellino S
    J Clin Med; 2016 Jul; 5(8):. PubMed ID: 27472373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acids and mood disorders.
    Parker G; Gibson NA; Brotchie H; Heruc G; Rees AM; Hadzi-Pavlovic D
    Am J Psychiatry; 2006 Jun; 163(6):969-78. PubMed ID: 16741195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids and neuropsychiatric disorders.
    Young G; Conquer J
    Reprod Nutr Dev; 2005; 45(1):1-28. PubMed ID: 15865053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology.
    Pusceddu MM; Kelly P; Stanton C; Cryan JF; Dinan TG
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids.
    Kidd PM
    Altern Med Rev; 2007 Sep; 12(3):207-27. PubMed ID: 18072818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation.
    Messamore E; McNamara RK
    Lipids Health Dis; 2016 Feb; 15():25. PubMed ID: 26860589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?
    Naguy A
    J Diet Suppl; 2018 Jan; 15(1):124-128. PubMed ID: 28558251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trim the fat: the role of omega-3 fatty acids in psychopharmacology.
    Nasir M; Bloch MH
    Ther Adv Psychopharmacol; 2019; 9():2045125319869791. PubMed ID: 31489174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acids in psychiatry: a review.
    Freeman MP
    Ann Clin Psychiatry; 2000 Sep; 12(3):159-65. PubMed ID: 10984006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acids for bipolar disorder.
    Montgomery P; Richardson AJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005169. PubMed ID: 18425912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
    Lin PY; Su KP
    J Clin Psychiatry; 2007 Jul; 68(7):1056-61. PubMed ID: 17685742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of n-3 polyunsaturated fatty acids (n-3PUFAs) in affective disorders.
    Ciappolino V; Delvecchio G; Agostoni C; Mazzocchi A; Altamura AC; Brambilla P
    J Affect Disord; 2017 Dec; 224():32-47. PubMed ID: 28089169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report.
    Freeman MP; Fava M; Lake J; Trivedi MH; Wisner KL; Mischoulon D
    J Clin Psychiatry; 2010 Jun; 71(6):669-81. PubMed ID: 20573326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.